Advanced search
Publication Cover
Epigenomics Volume 1, 2009 - Issue 2
Submit an article Journal homepage
371
Views
0
CrossRef citations to date
0
Altmetric
Review

Human Imprinting Syndromes

Derek HK Lim1 Birmingham Women‘s Hospital, BirminghamUK;2 Department of Medical & Molecular Genetics, School of Clinical and Experimental Medicine, University of Birmingham College of Medical and Dental Sciences, Edgbaston, Birmingham, B15 2TT, UK. Tel.: +44 0121 627 2741 Fax: +44 0121 627 2618
&
Eamonn R Maher1 Birmingham Women‘s Hospital, BirminghamUK;2 Department of Medical & Molecular Genetics, School of Clinical and Experimental Medicine, University of Birmingham College of Medical and Dental Sciences, Edgbaston, Birmingham, B15 2TT, UK. Tel.: +44 0121 627 2741 Fax: +44 0121 627 2618Correspondence[email protected]
Pages 347-369 | Published online: 03 Dec 2009

Bibliography

  • Reik W , WalterJ: Genomic imprinting: parental influence on the genome.Nat. Rev. Genet.2 , 21–32 (2001).
  • McGrath J , SolterD: Completion of mouse embryogenesis requires both the maternal and paternal genomes.Cell37 , 179–183 (1984).
  • Surani MA , BartonSC, NorrisML: Development of reconstituted mouse eggs suggests imprinting of the genome during gametogenesis.Nature308 , 548–550 (1984).
  • Kajii T , OhamaK: Androgenetic origin of hydatidiform mole.Nature268 , 633–634 (1977).
  • Ohama K , KajiiT, OkamotoE et al.: Dispermic origin of XY hydatidiform moles.Nature292 , 551–552 (1981).
  • Ohama K , NomuraK, OkamotoE, FukudaY, IharaT, FujiwaraA: Origin of immature teratoma of the ovary.Am. J. Obstet. Gynecol.152 , 896–900 (1985).
  • Cattanach BM , KirkM: Differential activity of maternally and paternally derived chromosome regions in mice.Nature315 , 496–498 (1985).
  • Barlow DP , StogerR, HerrmannBG, SaitoK, SchweiferN: The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus.Nature349 , 84–87 (1991).
  • Neumann B , KubickaP, BarlowDP: Characteristics of imprinted genes.Nat. Genet.9 , 12–13 (1995).
  • Jaenisch R , BirdA: Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals.Nat. Genet.33(Suppl.) , 245–254 (2003).
  • Dennis C : Epigenetics and disease: altered states.Nature421 , 686–688 (2003).
  • Horike S , MitsuyaK, MeguroM et al.: Targeted disruption of the human LIT1 locus defines a putative imprinting control element playing an essential role in Beckwith–Wiedemann syndrome.Hum. Mol. Genet.9 , 2075–2083 (2000).
  • Bell AC , FelsenfeldG: Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene.Nature405 , 482–485 (2000).
  • Lee J , InoueK, OnoR et al.: Erasing genomic imprinting memory in mouse clone embryos produced from day 11.5 primordial germ cells.Development129 , 1807–1817 (2002).
  • Szabo PE , HubnerK, ScholerH, MannJR: Allele-specific expression of imprinted genes in mouse migratory primordial germ cells.Mec. Dev.115 , 157–160 (2002).
  • Cooper WN , LuhariaA, EvansGA et al.: Molecular subtypes and phenotypic expression of Beckwith–Wiedemann syndrome.Eur. J. Hum. Genet.13 , 1025–1032 (2005).
  • Abu-Amero S , MonkD, FrostJ, PreeceM, StanierP, MooreGE: The genetic aetiology of Silver–Russell syndrome.J. Med. Genet.45 , 193–199 (2008).
  • Jirtle RL , SkinnerMK: Environmental epigenomics and disease susceptibility.Nat. Rev. Genet.8 , 253–262 (2007).
  • Coan PM , BurtonGJ, Ferguson-SmithAC: Imprinted genes in the placenta – a review.Placenta26(Suppl. A) , S10–S20 (2005).
  • Davies W , IslesAR, WilkinsonLS: Imprinted gene expression in the brain.Neurosci. Biobehav. Rev.29 , 421–430 (2005).
  • Hensen EF , JordanovaES, van Minderhout IJ et al.: Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families. Oncogene23 , 4076–4083 (2004).
  • Bartolomei MS , ZemelS, TilghmanSM: Parental imprinting of the mouse H19 gene.Nature351 , 153–155 (1991).
  • DeChiara TM , RobertsonEJ, EfstratiadisA: Parental imprinting of the mouse insulin-like growth factor II gene.Cell64 , 849–859 (1991).
  • Hark AT , SchoenherrCJ, KatzDJ, IngramRS, LevorseJM, TilghmanSM: CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus.Nature405 , 486–489 (2000).
  • Maher ER , ReikW: Beckwith–Wiedemann syndrome: imprinting in clusters revisited.J. Clin. Invest.105 , 247–252 (2000).
  • Wan LB , BartolomeiMS: Regulation of imprinting in clusters: noncoding RNAs versus insulators.Adv. Genet.61 , 207–223 (2008).
  • Smilinich NJ , DayCD, FitzpatrickGV et al.: A maternally methylated CpG island in KvLQT1 is associated with an antisense paternal transcript and loss of imprinting in Beckwith–Wiedemann syndrome.Proc. Natl Acad. Sci. USA96 , 8064–8069 (1999).
  • Diaz-Meyer N , DayCD, KhatodK et al.: Silencing of CDKN1C (p57KIP2) is associated with hypomethylation at KvDMR1 in Beckwith–Wiedemann syndrome.J. Med. Genet.40 , 797–801 (2003).
  • Lee MP , DeBaunMR, MitsuyaK et al.: Loss of imprinting of a paternally expressed transcript, with antisense orientation to KVLQT1, occurs frequently in Beckwith–Wiedemann syndrome and is independent of insulin-like growth factor II imprinting.Proc. Natl Acad. Sci. USA96 , 5203–5208 (1999).
  • Weksberg R , ShumanC, BeckwithJB: Beckwith–Wiedemann syndrome.Eur. J. Hum. Genet. (2009) (Epub ahead of print).
  • Smith AC , ChoufaniS, FerreiraJC, WeksbergR: Growth regulation, imprinted genes, and chromosome 11p15.5.Pediatr. Res.61 , R43–R47 (2007).
  • Haig D : Genomic imprinting and kinship: how good is the evidence?Annu. Rev. Genet.38 , 553–585 (2004).
  • Reik W , MaherER: Imprinting in clusters: lessons from Beckwith–Wiedemann syndrome.Trends Genet.13 , 330–334 (1997).
  • Slavotinek A , GauntL, DonnaiD: Paternally inherited duplications of 11p15.5 and Beckwith–Wiedemann syndrome.J. Med. Genet.34 , 819–826 (1997).
  • Elliott M , BaylyR, ColeT, TempleIK, MaherER: Clinical features and natural history of Beckwith–Wiedemann syndrome: presentation of 74 new cases.Clin. Genet.46 , 168–174 (1994).
  • Elliott M , MaherER: Beckwith–Wiedemann syndrome.J. Med. Genet.31 , 560–564 (1994).
  • Everman DB , ShumanC, DzolganovskiB, O‘RiordanMA, WeksbergR, RobinNH: Serum α-fetoprotein levels in Beckwith–Wiedemann syndrome.J. Pediatr.137 , 123–127 (2000).
  • Beckwith JB : Nephrogenic rests and the pathogenesis of Wilms tumor: developmental and clinical considerations.Am. J. Med. Genet.79 , 268–273 (1998).
  • Scott RH , WalkerL, OlsenOE et al.: Surveillance for Wilms tumor in at-risk children: pragmatic recommendations for best practice.Arch. Dis. Child.91 , 995–999 (2006).
  • Niemitz EL , DeBaunMR, FallonJ et al.: Microdeletion of LIT1 in familial Beckwith–Wiedemann syndrome.Am. J. Hum. Genet.75 , 844–849 (2004).
  • Sparago A , CerratoF, VernucciM, FerreroGB, SilengoMC, RiccioA: Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith–Wiedemann syndrome.Nat. Genet.36 , 958–960 (2004).
  • Sparago A , RussoS, CerratoF et al.: Mechanisms causing imprinting defects in familial Beckwith–Wiedemann syndrome with Wilms‘ tumor.Hum. Mol. Genet.16 , 254–264 (2007).
  • Scott RH , DouglasJ, BaskcombL et al.: Methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) robustly detects and distinguishes 11p15 abnormalities associated with overgrowth and growth retardation.J. Med. Genet.45 , 106–113 (2008).
  • Hatada I , OhashiH, FukushimaY et al.: An imprinted gene p57KIP2 is mutated in Beckwith–Wiedemann syndrome.Nat. Genet.14 , 171–173 (1996).
  • Lam WW , HatadaI, OhishiS et al.: Analysis of germline CDKN1C (p57KIP2) mutations in familial and sporadic Beckwith–Wiedemann syndrome (BWS) provides a novel genotype–phenotype correlation.J. Med. Genet.36 , 518–523 (1999).
  • Meyer E , LimD, PashaS et al.: Germline mutation in NLRP2 (NALP2) in a familial imprinting disorder (Beckwith–Wiedemann Syndrome).PLoS Genet.5 , E1000423 (2009).
  • Scott RH , DouglasJ, BaskcombL et al.: Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor.Nat. Genet.40 , 1329–1334 (2008).
  • Maher ER , BruetonLA, BowdinSC et al.: Beckwith–Wiedemann syndrome and assisted reproduction technology (ART).J. Med. Genet.40 , 62–64 (2003).
  • DeBaun MR , NiemitzEL, FeinbergAP: Association of in vitro fertilization with Beckwith–Wiedemann syndrome and epigenetic alterations of LIT1 and H19.Am. J. Hum. Genet.72 , 156–160 (2003).
  • Gicquel C , GastonV, MandelbaumJ, SiffroiJP, FlahaultA, Le Bouc Y: In vitro fertilization may increase the risk of Beckwith–Wiedemann syndrome related to the abnormal imprinting of the KCN1OT gene. Am. J. Hum. Genet.72 , 1338–1341 (2003).
  • Halliday J , OkeK, BrehenyS, AlgarE, J Amor D: Beckwith–Wiedemann syndrome and IVF: a case–control study. Am. J. Hum. Genet.75 , 526–528 (2004).
  • Rossignol S , SteunouV, ChalasC et al.: The epigenetic imprinting defect of patients with Beckwith–Wiedemann syndrome born after assisted reproductive technology is not restricted to the 11p15 region.J. Med. Genet.43 , 902–907 (2006).
  • Lim D , BowdinSC, TeeL et al.: Clinical and molecular genetic features of Beckwith–Wiedemann syndrome associated with assisted reproductive technologies.Hum. Reprod.24 , 741–747 (2009).
  • Bliek J , VerdeG, CallawayJ et al.: Hypomethylation at multiple maternally methylated imprinted regions including PLAGL1 and GNAS loci in Beckwith–Wiedemann syndrome.Eur. J. Hum. Genet.17 , 611–619 (2009).
  • Amor DJ , HallidayJ: A review of known imprinting syndromes and their association with assisted reproduction technologies.Hum. Reprod.23 , 2826–2834 (2008).
  • Manipalviratn S , DeCherneyA, SegarsJ: Imprinting disorders and assisted reproductive technology.Fertil. Steril.91 , 305–315 (2009).
  • Silver HK , KiyasuW, GeorgeJ, DeamerWC: Syndrome of congenital hemihypertrophy, shortness of stature, and elevated urinary gonadotropins.Pediatrics12 , 368–376 (1953).
  • Russell A : A syndrome of intra-uterine dwarfism recognizable at birth with cranio-facial dysostosis, disproportionately short arms, and other anomalies (5 examples).Proc. R. Soc. Med.47 , 1040–1044 (1954).
  • Price SM , StanhopeR, GarrettC, PreeceMA, TrembathRC: The spectrum of Silver–Russell syndrome: a clinical and molecular genetic study and new diagnostic criteria.J. Med. Genet.36 , 837–842 (1999).
  • Tomiyama H , IbukiT, NakajimaY, TanakaY: Late intraoperative hypoglycemia in a patient with Russell–Silver syndrome.J. Clin. Anesth.11 , 80–82 (1999).
  • Stanhope R , AlbaneseA, AzconaC: Growth hormone treatment of Russell–Silver syndrome.Horm. Res.49(Suppl. 2) , 37–40 (1998).
  • Anderson J , ViskochilD, O‘GormanM, GonzalesC: Gastrointestinal complications of Russell–Silver syndrome: a pilot study.Am. J. Med. Genet.113 , 15–19 (2002).
  • Duncan PA , HallJG, ShapiroLR, VibertBK: Three-generation dominant transmission of the Silver–Russell syndrome.Am. J. Med. Genet.35 , 245–250 (1990).
  • Rossignol S , NetchineI, Le Bouc Y, Gicquel C: Epigenetics in Silver–Russell syndrome. Best Pract. Res. Clin. Endocrinol. Metab.22 , 403–414 (2008).
  • Gicquel C , RossignolS, CabrolS et al.: Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver–Russell syndrome.Nat. Genet.37 , 1003–1007 (2005).
  • Netchine I , RossignolS, DufourgMN et al.: 11p15 imprinting center region 1 loss of methylation is a common and specific cause of typical Russell–Silver syndrome: clinical scoring system and epigenetic-phenotypic correlations.J. Clin. Endocrinol. Metab.92 , 3148–3154 (2007).
  • Schonherr N , MeyerE, RoosA, SchmidtA, WollmannHA, EggermannT: The centromeric 11p15 imprinting centre is also involved in Silver–Russell syndrome.J. Med. Genet.44 , 59–63 (2007).
  • Eggermann T , SchonherrN, MeyerE et al.: Epigenetic mutations in 11p15 in Silver–Russell syndrome are restricted to the telomeric imprinting domain.J. Med. Genet.43 , 615–616 (2006).
  • Binder G , SeidelAK, WeberK et al.: IGF-II serum levels are normal in children with Silver–Russell syndrome who frequently carry epimutations at the IGF2 locus.J. Clin. Endocrinol. Metab.91 , 4709–4712 (2006).
  • Bullman H , LeverM, RobinsonDO, MackayDJ, HolderSE, WakelingEL: Mosaic maternal uniparental disomy of chromosome 11 in a patient with Silver–Russell syndrome.J. Med. Genet.45 , 396–399 (2008).
  • Hannula K , KereJ, PirinenS, HolmbergC, Lipsanen-NymanM: Do patients with maternal uniparental disomy for chromosome 7 have a distinct mild Silver–Russell phenotype?J. Med. Genet.38 , 273–278 (2001).
  • van Haelst MM , EussenHJ, VisscherF et al.: Silver–Russell phenotype in a patient with pure trisomy 1q32.1-q42.1: further delineation of the pure 1q trisomy syndrome.J. Med. Genet.39 , 582–585 (2002).
  • Kennerknecht I , BarbiG, RodensK: Dup(1q)(q42-->qter) syndrome: case report and review of literature.Am. J. Med. Genet.47 , 1157–1160 (1993).
  • Ramirez-Duenas ML , MedinaC, Ocampo-CamposR, RiveraH: Severe Silver–Russell syndrome and translocation (17;20) (q25;q13).Clin. Genet.41 , 51–53 (1992).
  • Midro AT , DebekK, SawickaA, MarcinkiewiczD, RogowskaM: Second observation of Silver–Russel syndrome in a carrier of a reciprocal translocation with one breakpoint at site 17q25.Clin. Genet.44 , 53–55 (1993).
  • Dorr S , MidroAT, FarberC, GiannakudisJ, HansmannI: Construction of a detailed physical and transcript map of the candidate region for Russell–Silver syndrome on chromosome 17q23-q24.Genomics71 , 174–181 (2001).
  • Eggermann T , EggermannK, MergenthalerS et al.: Paternally inherited deletion of CSH1 in a patient with Silver–Russell syndrome.J. Med. Genet.35 , 784–786 (1998).
  • Prager S , WollmannHA, MergenthalerS et al.: Characterization of genomic variants in CSH1 and GH2, two candidate genes for Silver–Russell syndrome in 17q24-q25.Genet. Test.7 , 259–263 (2003).
  • Hitchins MP , S Abu-Amero, Apostolidou S et al.: Investigation of the GRB2, GRB7, and CSH1 genes as candidates for the Silver–Russell syndrome (SRS) on chromosome 17q. J. Med. Genet.39 , E13 (2002).
  • Eggermann T , SchonherrN, EggermannK, WollmannH: Hypomethylation in the 11p15 telomeric imprinting domain in a patient with Silver–Russell syndrome with a CSH1 deletion (17q24) renders a functional role of this alteration unlikely.J. Med. Genet.44 , E77 (2007).
  • Runte M , HuttenhoferA, GrossS, KiefmannM, HorsthemkeB, BuitingK: The IC-SNURF-SNRPN transcript serves as a host for multiple small nucleolar RNA species and as an antisense RNA for UBE3A.Hum. Mol. Genet.10 , 2687–2700 (2001).
  • Landers M , BancescuDL, Le Meur E et al.: Regulation of the large (approximately 1000 kb) imprinted murine Ube3a antisense transcript by alternative exons upstream of Snurf/Snrpn. Nucleic Acids Res.32 , 3480–3492 (2004).
  • Hulten M , ArmstrongS, ChallinorP et al.: Genomic imprinting in an Angelman and Prader–Willi translocation family.Lancet338 , 638–639 (1991).
  • Williams CA , BeaudetAL, Clayton-SmithJ et al.: Angelman syndrome 2005: updated consensus for diagnostic criteria.Am. J. Med. Genet. A140 , 413–418 (2006).
  • Williams CA : Neurological aspects of the Angelman syndrome.Brain Dev.27 , 88–94 (2005).
  • Butler MG , TheodoroMF, BittelDC, DonnellyJE: Energy expenditure and physical activity in Prader–Willi syndrome: comparison with obese subjects.Am. J. Med. Genet. A143 , 449–459 (2007).
  • Cassidy SB , DriscollDJ: Prader–Willi syndrome.Eur. J. Hum. Genet.17 , 3–13 (2009).
  • Whittington J , HollandA, WebbT, ButlerJ, ClarkeD, BoerH: Academic underachievement by people with Prader–Willi syndrome.J. Intellect. Disabil. Res.48 , 188–200 (2004).
  • Descheemaeker MJ , GoversV, VermeulenP, FrynsJP: Pervasive developmental disorders in Prader–Willi syndrome: the Leuven experience in 59 subjects and controls.Am. J. Med. Genet. A140 , 1136–1142 (2006).
  • Wigren M , HansenS: ADHD symptoms and insistence on sameness in Prader–Willi syndrome.J. Intellect. Disabil. Res.49 , 449–456 (2005).
  • Steinhausen HC , EiholzerU, HauffaBP, MalinZ: Behavioural and emotional disturbances in people with Prader–Willi Syndrome.J. Intellect. Disabil. Res.48 , 47–52 (2004).
  • Festen DA , de Weerd AW, van den Bossche RA, Joosten K, Hoeve H, Hokken-Koelega AC: Sleep-related breathing disorders in prepubertal children with Prader–Willi syndrome and effects of growth hormone treatment. J. Clin. Endocrinol. Metab.91 , 4911–4915 (2006).
  • Priano L , GrugniG, MiscioG et al.: Sleep cycling alternating pattern (CAP) expression is associated with hypersomnia and GH secretory pattern in Prader–Willi syndrome.Sleep Med.7 , 627–633 (2006).
  • Fan Z , GreenwoodR, FisherA, PendyalS, PowellCM: Characteristics and frequency of seizure disorder in 56 patients with Prader–Willi syndrome.Am. J. Med. Genet. A149A , 1581–1584 (2009).
  • Crino A , SchiaffiniR, CiampaliniP et al.: Hypogonadism and pubertal development in Prader–Willi syndrome.Eur J. Pediatr.162 , 327–333 (2003).
  • Akefeldt A , TornhageCJ, GillbergC: ‘A woman with Prader–Willi syndrome gives birth to a healthy baby girl‘.Dev. Med. Child Neurol.41 , 789–790 (1999).
  • Schulze A , MogensenH, Hamborg-PetersenB, GraemN, OstergaardJR, Brondum-NielsenK: Fertility in Prader–Willi syndrome: a case report with Angelman syndrome in the offspring.Acta Paediatr.90 , 455–459 (2001).
  • Burman P , RitzenEM, LindgrenAC: Endocrine dysfunction in Prader–Willi syndrome: a review with special reference to GH.Endocr. Rev.22 , 787–799 (2001).
  • Gunay-Aygun M , SchwartzS, HeegerS, O‘RiordanMA, CassidySB: The changing purpose of Prader–Willi syndrome clinical diagnostic criteria and proposed revised criteria.Pediatrics108 , E92 (2001).
  • Magenis RE , Toth-FejelS, AllenLJ et al.: Comparison of the 15q deletions in Prader–Willi and Angelman syndromes: specific regions, extent of deletions, parental origin, and clinical consequences.Am. J. Med. Genet.35 , 333–349 (1990).
  • Zori R , WilliamsC, MatteiJF, MonclaA: Parental origin of del(15)(q11-q13) in Angelman and Prader–Willi syndromes.Am. J. Med. Genet.37 , 294–295 (1990).
  • Knoll JH , NichollsRD, MagenisRE, GrahamJM Jr, Lalande M, Latt SA: Angelman and Prader–Willi syndromes share a common chromosome 15 deletion but differ in parental origin of the deletion. Am. J. Med. Genet.32 , 285–290 (1989).
  • Nicholls RD , KnollJH, ButlerMG, KaramS, LalandeM: Genetic imprinting suggested by maternal heterodisomy in nondeletion Prader–Willi syndrome.Nature342 , 281–285 (1989).
  • Knoll JH , GlattKA, NichollsRD, MalcolmS, LalandeM: Chromosome 15 uniparental disomy is not frequent in Angelman syndrome.Am. J. Hum. Genet.48 , 16–21 (1991).
  • Kishino T , LalandeM, WagstaffJ: UBE3A/E6-AP mutations cause Angelman syndrome.Nat. Genet.15 , 70–73 (1997).
  • Matsuura T , SutcliffeJS, FangP et al.: De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome.Nat. Genet.15 , 74–77 (1997).
  • Sahoo T , del Gaudio D, German JR et al.: Prader–Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster. Nat. Genet.40 , 719–721 (2008).
  • de Smith AJ , PurmannC, WaltersRG et al.: A deletion of the HBII-85 class of small nucleolar RNAs (snoRNAs) is associated with hyperphagia, obesity and hypogonadism.Hum. Mol. Genet.18 , 3257–3265 (2009).
  • Gallagher RC , PilsB, AlbalwiM, FranckeU: Evidence for the role of PWCR1/HBII-85 C/D box small nucleolar RNAs in Prader–Willi syndrome.Am. J. Hum. Genet.71 , 669–678 (2002).
  • Schule B , AlbalwiM, NorthropE et al.: Molecular breakpoint cloning and gene expression studies of a novel translocation t(4;15)(q27;q11.2) associated with Prader–Willi syndrome.BMC Med. Genet.6 , 18 (2005).
  • Horsthemke B , BuitingK: Imprinting defects on human chromosome 15.Cytogenet. Genome Res.113 , 292–299 (2006).
  • Buiting K , LichC, CottrellS, BarnicoatA, HorsthemkeB: A 5-kb imprinting center deletion in a family with Angelman syndrome reduces the shortest region of deletion overlap to 880 bp.Hum. Genet.105 , 665–666 (1999).
  • Bielinska B , BlaydesSM, BuitingK et al.: De novo deletions of SNRPN exon 1 in early human and mouse embryos result in a paternal to maternal imprint switch.Nat. Genet.25 , 74–78 (2000).
  • Horsthemke B , WagstaffJ: Mechanisms of imprinting of the Prader–Willi/Angelman region.Am. J. Med. Genet. A146A , 2041–2052 (2008).
  • Sahoo T , PetersSU, MadduriNS et al.: Microarray based comparative genomic hybridization testing in deletion bearing patients with Angelman syndrome: genotype–phenotype correlations.J. Med. Genet.43 , 512–516 (2006).
  • Lossie AC , WhitneyMM, AmidonD et al.: Distinct phenotypes distinguish the molecular classes of Angelman syndrome.J. Med. Genet.38 , 834–845 (2001).
  • Saitoh S , WadaT, OkajimaM, TakanoK, SudoA, NiikawaN: Uniparental disomy and imprinting defects in Japanese patients with Angelman syndrome.Brain Dev.27 , 389–391 (2005).
  • Nazlican H , ZeschnigkM, ClaussenU et al.: Somatic mosaicism in patients with Angelman syndrome and an imprinting defect.Hum. Mol. Genet.13 , 2547–2555 (2004).
  • Cox GF , BurgerJ, LipV et al.: Intracytoplasmic sperm injection may increase the risk of imprinting defects.Am. J. Hum. Genet.71 , 162–164 (2002).
  • Orstavik KH , EiklidK, van der Hagen CB et al.: Another case of imprinting defect in a girl with Angelman syndrome who was conceived by intracytoplasmic semen injection. Am. J. Hum. Genet.72 , 218–219 (2003).
  • Ludwig M , KatalinicA, GrossS, SutcliffeA, VaronR, HorsthemkeB: Increased prevalence of imprinting defects in patients with Angelman syndrome born to subfertile couples.J. Med. Genet.42 , 289–291 (2005).
  • Kamiya M , JudsonH, OkazakiY et al.: The cell cycle control gene ZAC/PLAGL1 is imprinted – a strong candidate gene for transient neonatal diabetes.Hum. Mol. Genet.9 , 453–460 (2000).
  • Arima T , DrewellRA, ArneyKL et al.: A conserved imprinting control region at the HYMAI/ZAC domain is implicated in transient neonatal diabetes mellitus.Hum. Mol. Genet.10 , 1475–1483 (2001).
  • Mackay DJ , CoupeAM, ShieldJP, StorrJN, TempleIK, RobinsonDO: Relaxation of imprinted expression of ZAC and HYMAI in a patient with transient neonatal diabetes mellitus.Hum. Genet.110 , 139–144 (2002).
  • Gardner RJ , MackayDJ, MungallAJ et al.: An imprinted locus associated with transient neonatal diabetes mellitus.Hum. Mol. Genet.9 , 589–596 (2000).
  • Temple IK , ShieldJP: Transient neonatal diabetes, a disorder of imprinting.J. Med. Genet.39 , 872–875 (2002).
  • Temple IK , GardnerRJ, MackayDJ, BarberJC, RobinsonDO, ShieldJP: Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes.Diabetes49 , 1359–1366 (2000).
  • Temple IK : Imprinting in human disease with special reference to transient neonatal diabetes and Beckwith–Wiedemann syndrome.Endocr. Dev.12 , 113–123 (2007).
  • Mackay DJ , BoonenSE, Clayton-SmithJ et al.: A maternal hypomethylation syndrome presenting as transient neonatal diabetes mellitus.Hum. Genet.120 , 262–269 (2006).
  • Mackay DJ , HahnemannJM, BoonenSE et al.: Epimutation of the TNDM locus and the Beckwith–Wiedemann syndrome centromeric locus in individuals with transient neonatal diabetes mellitus.Hum. Genet.119 , 179–184 (2006).
  • Mackay DJ , CallawayJL, MarksSM et al.: Hypomethylation of multiple imprinted loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57.Nat. Genet.40 , 949–951 (2008).
  • Li X , ItoM, ZhouF et al.: A maternal-zygotic effect gene, Zfp57, maintains both maternal and paternal imprints.Dev. Cell15 , 547–557 (2008).
  • Lin SP , YoungsonN, TakadaS et al.: Asymmetric regulation of imprinting on the maternal and paternal chromosomes at the Dlk1-Gtl2 imprinted cluster on mouse chromosome 12.Nat. Genet.35 , 97–102 (2003).
  • Geuns E , De Temmerman N, Hilven P, Van Steirteghem A, Liebaers I, De Rycke M: Methylation analysis of the intergenic differentially methylated region of DLK1-GTL2 in human. Eur. J. Hum. Genet.15 , 352–361 (2007).
  • Edwards CA , Ferguson-SmithAC: Mechanisms regulating imprinted genes in clusters.Curr. Opin. Cell Biol.19 , 281–289 (2007).
  • Temple IK , CockwellA, HassoldT, PettayD, JacobsP: Maternal uniparental disomy for chromosome 14.J. Med. Genet.28 , 511–514 (1991).
  • Kotzot D , UtermannG: Uniparental disomy (UPD) other than 15: phenotypes and bibliography updated.Am. J. Med. Genet. A136 , 287–305 (2005).
  • Mitter D , BuitingK, von Eggeling F et al.: Is there a higher incidence of maternal uniparental disomy 14 [upd(14)mat]? Detection of 10 new patients by methylation-specific PCR. Am. J. Med. Genet. A140 , 2039–2049 (2006).
  • Cox H , BullmanH, TempleIK: Maternal UPD(14) in the patient with a normal karyotype: clinical report and a systematic search for cases in samples sent for testing for Prader–Willi syndrome.Am. J. Med. Genet. A127A , 21–25 (2004).
  • Kagami M , SekitaY, NishimuraG et al.: Deletions and epimutations affecting the human 14q32.2 imprinted region in individuals with paternal and maternal upd(14)-like phenotypes.Nat. Genet.40 , 237–242 (2008).
  • Temple IK , ShrubbV, LeverM, BullmanH, MackayDJ: Isolated imprinting mutation of the DLK1/GTL2 locus associated with a clinical presentation of maternal uniparental disomy of chromosome 14.J. Med. Genet.44 , 637–640 (2007).
  • Kurosawa K , SasakiH, SatoY et al.: Paternal UPD14 is responsible for a distinctive malformation complex.Am. J. Med. Genet.110 , 268–272 (2002).
  • Offiah AC , CornetteL, HallCM: Paternal uniparental disomy 14: introducing the ‘coat-hanger‘ sign.Pediatr. Radiol.33 , 509–512 (2003).
  • Curtis L , AntonelliE, VialY et al.: Prenatal diagnostic indicators of paternal uniparental disomy 14.Prenat. Diagn.26 , 662–666 (2006).
  • Seitz H , YoungsonN, LinSP et al.: Imprinted microRNA genes transcribed antisense to a reciprocally imprinted retrotransposon-like gene.Nat. Genet.34 , 261–262 (2003).
  • Davis E , CaimentF, TordoirX et al.: RNAi-mediated allelic trans-interaction at the imprinted Rtl1/Peg11 locus.Curr. Biol.15 , 743–749 (2005).
  • Sekita Y , WagatsumaH, NakamuraK et al.: Role of retrotransposon-derived imprinted gene, Rtl1, in the feto-maternal interface of mouse placenta.Nat. Genet.40 , 243–248 (2008).
  • Weinstein LS , YuS, WarnerDR, LiuJ: Endocrine manifestations of stimulatory G protein α-subunit mutations and the role of genomic imprinting.Endocr. Rev.22 , 675–705 (2001).
  • Peters J , WroeSF, WellsCA et al.: A cluster of oppositely imprinted transcripts at the Gnas locus in the distal imprinting region of mouse chromosome 2.Proc. Natl Acad. Sci. USA96 , 3830–3835 (1999).
  • Liu J , YuS, LitmanD, ChenW, WeinsteinLS: Identification of a methylation imprint mark within the mouse Gnas locus.Mol. Cell. Biol20 , 5808–5817 (2000).
  • Kehlenbach RH , MattheyJ, HuttnerWB: XL α s is a new type of G protein.Nature372 , 804–809 (1994).
  • Wroe SF , KelseyG, SkinnerJA et al.: An imprinted transcript, antisense to Nesp, adds complexity to the cluster of imprinted genes at the mouse Gnas locus.Proc. Natl Acad. Sci. USA97 , 3342–3346 (2000).
  • Yu S , YuD, LeeE et al.: Variable and tissue-specific hormone resistance in heterotrimeric Gs protein α-subunit (Gsα) knockout mice is due to tissue-specific imprinting of the gsα gene.Proc. Natl Acad. Sci. USA95 , 8715–8720 (1998).
  • Hayward BE , KamiyaM, StrainL et al.: The human GNAS1 gene is imprinted and encodes distinct paternally and biallelically expressed G proteins.Proc. Natl Acad. Sci. USA95 , 10038–10043 (1998).
  • Hayward BE , MoranV, StrainL, BonthronDT: Bidirectional imprinting of a single gene: GNAS1 encodes maternally, paternally, and biallelically derived proteins.Proc. Natl Acad. Sci. USA95 , 15475–15480 (1998).
  • Williamson CM , BallST, NottinghamWT et al.: A cis-acting control region is required exclusively for the tissue-specific imprinting of Gnas.Nat. Genet.36 , 894–899 (2004).
  • Liu J , NealonJG, WeinsteinLS: Distinct patterns of abnormal GNAS imprinting in familial and sporadic pseudohypoparathyroidism type IB.Hum. Mol. Genet.14 , 95–102 (2005).
  • Williamson CM , TurnerMD, BallST et al.: Identification of an imprinting control region affecting the expression of all transcripts in the Gnas cluster.Nat. Genet.38 , 350–355 (2006).
  • de Nanclares GP , Fernandez-RebolloE, SantinI et al.: Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright‘s hereditary osteodystrophy.J. Clin. Endocrinol. Metab.92 , 2370–2373 (2007).
  • Davies SJ , HughesHE: Imprinting in Albright‘s hereditary osteodystrophy.J. Med. Genet.30 , 101–103 (1993).
  • Aldred MA , AftimosS, HallC et al.: Constitutional deletion of chromosome 20q in two patients affected with albright hereditary osteodystrophy.Am. J. Med. Genet.113 , 167–172 (2002).
  • Mantovani G , SpadaA: Mutations in the Gs α gene causing hormone resistance.Best Pract. Res. Clin. Endocrinol. Metab.20 , 501–513 (2006).
  • Liu J , ErlichmanB, WeinsteinLS: The stimulatory G protein α-subunit Gs α is imprinted in human thyroid glands: implications for thyroid function in pseudohypoparathyroidism types 1A and 1B.J. Clin. Endocrinol. Metab.88 , 4336–4341 (2003).
  • Bastepe M , FrohlichLF, HendyGN et al.: Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS.J. Clin. Invest.112 , 1255–1263 (2003).
  • Liu J , LitmanD, RosenbergMJ, YuS, BieseckerLG, WeinsteinLS: A GNAS1 imprinting defect in pseudohypoparathyroidism type IB.J. Clin. Invest.106 , 1167–1174 (2000).
  • Bastepe M , PincusJE, SugimotoT et al.: Positional dissociation between the genetic mutation responsible for pseudohypoparathyroidism type Ib and the associated methylation defect at exon A/B: evidence for a long-range regulatory element within the imprinted GNAS1 locus.Hum. Mol. Genet.10 , 1231–1241 (2001).
  • Jan de Beur S , DingC, Germain-LeeE, ChoJ, MaretA, LevineMA: Discordance between genetic and epigenetic defects in pseudohypoparathyroidism type 1b revealed by inconsistent loss of maternal imprinting at GNAS1.Am. J. Hum. Genet.73 , 314–322 (2003).
  • Bastepe M , LaneAH, JuppnerH: Paternal uniparental isodisomy of chromosome 20q – and the resulting changes in GNAS1 methylation – as a plausible cause of pseudohypoparathyroidism.Am. J. Hum. Genet.68 , 1283–1289 (2001).
  • El-Maarri O , SeoudM, CoullinP et al.: Maternal alleles acquiring paternal methylation patterns in biparental complete hydatidiform moles.Hum. Mol. Genet.12 , 1405–1413 (2003).
  • Fisher RA , HodgesMD, ReesHC et al.: The maternally transcribed gene p57(KIP2) (CDNK1C) is abnormally expressed in both androgenetic and biparental complete hydatidiform moles.Hum. Mol. Genet.11 , 3267–3272 (2002).
  • Judson H , HaywardBE, SheridanE, BonthronDT: A global disorder of imprinting in the human female germ line.Nature416 , 539–542 (2002).
  • Murdoch S , DjuricU, MazharB et al.: Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans.Nat. Genet.38 , 300–302 (2006).
  • Zhang P , DixonM, ZucchelliM et al.: Expression analysis of the NLRP gene family suggests a role in human preimplantation development.PLoS ONE3 , e2755 (2008).
  • Djuric U , El-MaarriO, LambB et al.: Familial molar tissues due to mutations in the inflammatory gene, NALP7, have normal postzygotic DNA methylation.Hum. Genet.120 , 390–395 (2006).
  • Kinoshita T , WangY, HasegawaM, ImamuraR, SudaT: PYPAF3, a PYRIN-containing APAF-1-like protein, is a feedback regulator of caspase-1-dependent interleukin-1b secretion.J. Biol. Chem.280 , 21720–21725 (2005).
  • Drenth JP , van der Meer JW: The inflammasome – a linebacker of innate defense. N. Engl. J. Med.355 , 730–732 (2006).
  • Hoffman HM , MuellerJL, BroideDH, WandererAA, KolodnerRD: Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle–Wells syndrome.Nat. Genet.29 , 301–305 (2001).
  • Jeru I , DuquesnoyP, Fernandes-AlnemriT et al.: Mutations in NALP12 cause hereditary periodic fever syndromes.Proc. Natl Acad. Sci. USA105 , 1614–1619 (2008).
  • Jin Y , MaillouxCM, GowanK et al.: NALP1 in vitiligo-associated multiple autoimmune disease.N. Engl. J. Med.356 , 1216–1225 (2007).
  • Bestor TH : Cytosine methylation mediates sexual conflict.Trends Genet.19 , 185–190 (2003).
  • Van den Veyver IB , Al-HussainiTK: Biparental hydatidiform moles: a maternal effect mutation affecting imprinting in the offspring.Hum. Reprod. Update12 , 233–242 (2006).
  • Deveault C , QianJH, ChebaroW et al.: NLRP7 mutations in women with diploid androgenetic and triploid moles: a proposed mechanism for mole formation.Hum. Mol. Genet.18 , 888–897 (2009).
  • American Association for Cancer Research Human Epigenome Task Force; European Union, Network of Excellence, Scientific Advisory Board: Moving AHEAD with an international human epigenome project. Nature454 , 711–715 (2008).
  • Hansen M , KurinczukJJ, BowerC, WebbS: The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization.N. Engl. J. Med.346 , 725–730 (2002).
  • Feinberg AP : Epigenetics at the epicenter of modern medicine.JAMA299 , 1345–1350 (2008).
  • Van Buggenhout G , FrynsJP: Angelman syndrome (AS, MIM 10.830).Eur. J. Hum. Genet.17(11) , 1367–1373 (2009).
  • Wilson LC , TrembathRC: Albright‘s hereditary osteodystrophy.J. Med. Genet.31 , 779–84 (1994).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.